首页> 外文期刊>Journal of neurosurgery. >Aneurysm-related subarachnoid hemorrhage and acute subdural hematoma: single-center series and systematic review Clinical article
【24h】

Aneurysm-related subarachnoid hemorrhage and acute subdural hematoma: single-center series and systematic review Clinical article

机译:与动脉瘤相关的蛛网膜下腔出血和急性硬膜下血肿:单中心系列和系统评价临床文章

获取原文
获取原文并翻译 | 示例
       

摘要

Object. Subarachnoid hemorrhage (SAH) with simultaneous acute subdural hematoma (SDH) is a severe disease. The authors' objective was to analyze the incidence, prognosis, and clinical outcome of patients suffering from aneurysm-related SAH and space-occupying acute SDH.Methods. Between June 1999 and June 2011, data from 989 patients with aneurysm-related SAH were prospec-tively entered into a database. Eighteen patients (1.8%) presented with aneurysm-related SAH and space-occupying acute SDH. The treatment decision (clip or coil) was based on an interdisciplinary approach. Outcome was assessed according to the modified Rankin Scale (mRS) at 6 months and was dichotomized into favorable outcome (mRS Score 0-2) versus unfavorable outcome (mRS Score 3-6). PubMed was searched for published studies of aneurysm-related SAH and acute SDH to gain a larger population. A multivariate regression analysis was performed on the pooled data.Results. Literature data, including the current series, revealed a total of 111 patients. Overall, 38 (34%) of 111 patients with aneurysm-related SAH and acute SDH achieved favorable outcome. Favorable outcome was achieved in 68% of patients with good-grade clinical presentation on admission (Hunt and Hess Grades I-UI) versus 23% of the patients with poor-grade presentation (Hunt and Hess Grades IV and V, p < 0.0001). In the multivariate analysis, poor clinical condition at admission was the only predictor for unfavorable outcome (p = 0.02).Conclusions. The present data confirm that patients with aneurysm-related SAH and acute SDH, even when presenting in poor clinical condition, might achieve favorable outcome. Therefore, treatment of patients with SAH and acute SDH should not be discontinued, but careful individual decision making is necessary for each patient.
机译:目的。蛛网膜下腔出血(SAH)并发急性急性硬膜下血肿(SDH)是一种严重疾病。作者的目的是分析患有动脉瘤相关SAH和占位性急性SDH的患者的发病率,预后和临床结果。在1999年6月至2011年6月之间,将989名与动脉瘤相关的SAH患者的数据预期输入了数据库。 18例(1.8%)患者出现了与动脉瘤相关的SAH和占位性急性SDH。治疗决策(夹子或线圈)基于跨学科方法。在6个月时根据改良的Rankin量表(mRS)评估结果,并将结果分为有利结局(mRS评分0-2)与不利结局(mRS评分3-6)。搜索PubMed以获取有关动脉瘤相关SAH和急性SDH的已发表研究,以增加人群。对汇总数据进行了多元回归分析。包括当前系列在内的文献数据共显示111例患者。总体而言,在111例与动脉瘤相关的SAH和急性SDH患者中,有38例(34%)取得了良好的疗效。入院时临床表现良好的患者中有68%达到了良好的结局(Hunt和Hess I-UI级),较差表现患者中23%的患者获得了良好的结局(Hunts和Hess IV和V级,p <0.0001) 。在多变量分析中,入院时临床状况不佳是导致预后不良的唯一预测因素(p = 0.02)。目前的数据证实,即使在临床状况不佳时,与动脉瘤相关的SAH和急性SDH的患者也可能取得良好的疗效。因此,不应中断对SAH和急性SDH患者的治疗,但必须对每位患者进行谨慎的个人决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号